Veps

Latham & Watkins Launches Virtual Experience Program on Capital Markets Law

Retrieved on: 
Tuesday, June 20, 2023
Learning, Veps, Competition law, IPO, Life, Capital market, Intellectual property, Queensland Recruiting Committee, Lawyer, VEP, Special, Competition, Forage, Public company, Mergers and acquisitions, Growth, Investment company, Female, Nursing, Security (finance)

NEW YORK, June 20, 2023 /PRNewswire/ -- Latham & Watkins LLP1 has launched the firm's newest Virtual Experience Program (VEP) on capital markets law. The free virtual program gives the business, academic, and legal communities the opportunity to represent the underwriters in an initial public offering (IPO), while learning about the nature of work at a global law firm. Participants will review corporate records, prepare an auditor "circle-up" on financial metrics, draft a principal stockholder table, and review a lock-up agreement in connection with an IPO.

Key Points: 
  • NEW YORK, June 20, 2023 /PRNewswire/ -- Latham & Watkins LLP1 has launched the firm's newest Virtual Experience Program (VEP) on capital markets law.
  • This program highlights the critical role capital markets lawyers play in supporting clients' growth and success, from IPO through their life as a public company.
  • The Capital Markets VEP launch marks Latham's eighth program on Forage, an innovative, open-access platform connecting users with companies and law firms.
  • To learn more about our Capital Markets Practice and careers at Latham, visit lwcareers.com.

Latham & Watkins Expands Virtual Experience Program Series With Intellectual Property Litigation Offering

Retrieved on: 
Monday, July 11, 2022
CCPIT Patent & Trademark Law Office, Partnership, VEP, Anatomy, Industry, Queensland Recruiting Committee, Program, Latham & Watkins, United Kingdom, Lawyer, Mergers & Acquisitions, Watkins, IP, Multimedia, Lists of companies, Intellectual property, Veps, Patent, Law, Competition, Special, NEW, Mergers and acquisitions, Foreign Legal Consultant, Kingdom, Property management, Insurance

NEW YORK, July 11, 2022 /PRNewswire/ -- Latham & Watkins LLP1 is pleased to announce the launch of the Intellectual Property Litigation Virtual Experience Program (VEP), the latest offering in the firm's VEP series. The program gives participants, particularly law students and other aspiring legal professionals, an interactive opportunity to learn more about the nature of a global law firm's practice through a patent litigation lens.  

Key Points: 
  • NEW YORK, July 11, 2022 /PRNewswire/ -- Latham & Watkins LLP1 is pleased to announce the launch of the Intellectual Property Litigation Virtual Experience Program (VEP), the latest offering in the firm's VEP series.
  • "Our IP litigation clients demand trial lawyers who can leverage deep technical knowledge, industry insight, and litigation experience across venues to protect their most important assets," said David Callahan, Global Chair of Latham's Intellectual Property Litigation Practice.
  • "We designed this program to provide the next generation of IP litigators real-world experience that they can expect to see in practice."
  • The Intellectual Property Litigation VEP launch marks Latham's seventh VEP on Forage, an innovative, open-access platform connecting users with companies and law firms.

Pipeline Therapeutics Reports Positive Phase 1 Clinical Results for PIPE-307, a Neuroregenerative Therapeutic for the Treatment of Multiple Sclerosis

Retrieved on: 
Thursday, March 10, 2022
Biotechnology, Pharmaceutical, Health, Clinical Trials, Safety, Attention, Multiple sclerosis, Volunteering, Single, Senior, MAD, Company, IND, MS, Pharmacokinetics, Even and odd functions, Total survey error, Food, CNS, Neurodegeneration, Investigational New Drug, Inflammatory demyelinating diseases of the central nervous system, Learning, Patient, SAD, US Foods, Nerve, Therapy, PK, Program, CEO, Veps, Adult, Neuro, LinkedIn, Pharmaceutical industry, Pipeline, PIPE-307 for Multiple Sclerosis, Pipeline Therapeutics, PIPE-307 FOR MULTIPLE SCLEROSIS, PIPELINE THERAPEUTICS

Currently, there are no approved medicines that support myelin restoration, which represents a significant unmet medical need in the treatment of MS.

Key Points: 
  • Currently, there are no approved medicines that support myelin restoration, which represents a significant unmet medical need in the treatment of MS.
  • The Phase 1 clinical results reported today comprised multiple dose cohorts of PIPE-307 in a total of 70 healthy volunteer subjects.
  • We believe that PIPE-307, as a first-in-class myelin restoration therapeutic, represents a differentiated and clinically-validated approach for the treatment of MS.
  • These encouraging Phase 1 results give us great confidence to advance PIPE-307 into clinical studies with MS patients as soon as possible.

UIW Study Finds Special Glasses Help Color Blind See Colors Better

Retrieved on: 
Monday, February 7, 2022
Education, Health, Consumer, Women, Men, Optical, University, People, Sport, NCAA, UIW, Founders Hall, Multimedia, Assessment, Conference, Research, University of the Incarnate Word, Color, Hispanic-serving institution, Quality of life, Student, Heart, University, Catholic higher education, Severe cognitive impairment, Learning, Male, Sister, Graduate school, Veps, Communication, Occupation, Catholic (term), Television, Interior design, Central Texas, EnChroma

View the full release here: https://www.businesswire.com/news/home/20220207005020/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220207005020/en/
    Normal color vision versus red-green color vision deficient view of a hot air balloon.
  • In the study, thirteen color blind subjects were given the special color-correcting lenses developed by EnChroma and wore them daily for 11 to 14 days.
  • Since the color blind cannot properly receive signals from specific color cones, the results indicate that EnChroma glasses activate the neural mechanisms required to better see colors and improve and expand color vision for those with red-green color vision deficiencies.
  • To those with color vision deficiency, colors appear muted, confusing at times and some colors are difficult to differentiate.

Latham & Watkins Launches Virtual Antitrust and Competition Law Program

Retrieved on: 
Monday, June 7, 2021
Law firms, Latham & Watkins, Veps, Latham

NEW YORK, June 7, 2021 /PRNewswire/ -- Latham & Watkins LLP1 is pleased to launch the firm's newest Virtual Experience Program (VEP) on antitrust and competition law.

Key Points: 
  • NEW YORK, June 7, 2021 /PRNewswire/ -- Latham & Watkins LLP1 is pleased to launch the firm's newest Virtual Experience Program (VEP) on antitrust and competition law.
  • Mandy Reeves, Chair of Latham's Global Antitrust & Competition Practice, said: "The Virtual Experience Program provides students and anyone interested in antitrust law the exciting opportunity to gain 'life-like' exposure to the legal issues surrounding a merger clearance.
  • With the launch of the Antitrust VEP, Latham now offers five VEPs on Forage: M&A , White Collar , Emerging Companies , Banking , and Antitrust .
  • Latham & Watkins works in cooperation with the Law Office of Salman M. Al-Sudairi in the Kingdom of Saudi Arabia.

Latham & Watkins Launches Virtual Experience Program on Banking Law

Retrieved on: 
Tuesday, June 30, 2020
Law firms, Veps, Latham

NEW YORK, June 30, 2020 /PRNewswire/ --Latham & Watkins LLP1 is pleased to announce the launch of the firm's Virtual Experience Program (VEP) on banking law.

Key Points: 
  • NEW YORK, June 30, 2020 /PRNewswire/ --Latham & Watkins LLP1 is pleased to announce the launch of the firm's Virtual Experience Program (VEP) on banking law.
  • Dan Seale, Global Chair of Latham's Banking Practice, said: "The Virtual Experience Program provides students and anyone interested in banking law the exciting opportunity to gain 'life like' exposure to the legal issues surrounding a financing.
  • With the launch of the Banking VEP, Latham now offers four VEPs on InsideSherpa: M&A , White Collar , Emerging Companies , and Banking .
  • "Our Virtual Experience Program helps demystify big law, offering a rare window into the work of a corporate attorney.

Headsafe Announces FDA Clearance and U.S. Launch of its NUROCHEK™ Portable Brain Assessment System

Retrieved on: 
Wednesday, May 6, 2020
Branches of biology, Neuroscience, Medicine, Neurotechnology, Electrodiagnosis, Medical tests, Brain–computer interfacing, Evoked potential, Veps, Electroencephalography

The NUROCHEK system is intended for use in patients aged 14 years and older as indicator of brain function and is the worlds first portable Visual Evoked Potential (VEP) testing system for use at the point-of-care.

Key Points: 
  • The NUROCHEK system is intended for use in patients aged 14 years and older as indicator of brain function and is the worlds first portable Visual Evoked Potential (VEP) testing system for use at the point-of-care.
  • The NUROCHEK system is a portable brain assessment device that provides an objective measure of brain function that utilizes VEPs.
  • In under 3 minutes, the NUROCHEK system captures and transmits VEP stimulated Electroencephalography (EEG) data to a smartphone application for processing and secure cloud storage.
  • The companys NUROCHEK portable brain assessment system is cleared for use in the United States and will become available in other regions subject to regulatory approvals.